Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label study of Elaprase initiated before age 6 in patients with MPS II
2014-004804-31Phase 4Completed
- Sponsor
- Takeda
- Start
- Aug 2015
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of idursulfase in mucopolysaccharidosis type 2, sponsored by Takeda. Primary endpoint: Primary longitudinal growth endpoints. Started Aug 2015; status: completed.
02
Drugs
idursulfase
03
Conditions
mucopolysaccharidosis type 2
Beyond the preview
Go deeper on 2014-004804-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004804-31.